Perinatal implications of maternal hypertension

Seminars in Pediatric Neurology

Volumn 8, Issue 2, 2001, Pages 108-119

  Shah, Dinesh M ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE CLASSIFICATION; ECLAMPSIA; HUMAN; MATERNAL HYPERTENSION; PATHOPHYSIOLOGY; PERINATAL DEVELOPMENT; PLACENTA CIRCULATION; PREECLAMPSIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 0034946546     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1053/spen.2001.25812     Document Type: Article

References (82)

1. National High Blood Pressure Education Program Working Group reports on high blood pressure during pregnancy
2. On the pathogenesis of pre-eclampsia and eclampsia
3. On pathogenesis of placental infarcts in pre-eclampsia
4. Placental bed spiral arteries in the hypertensive disorders of pregnancy
5. An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation
6. Fetal outcome in hypertensive disorders of pregnancy
7. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy
8. The maternal placental blood flow in normotensive and hypertensive women
9. Uteroplacental blood flow in pregnancy induced hypertension
10. Comparison of uteroplacental vasculature and circulation in the rhesus monkey and man
11. The morphology of human uteroplacental vasculature
12. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy
13. Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy
14. Ultrastructural aspects of preeclampsia
15. Prostaglandins and the regulation of uterine blood flow in pregnancy
16. Synthesis and release of endothelin-1 by human decidual cells
17. Endothelium-derived relaxation of the pregnant and nonpregnant canine uterine artery
18. Human spiral artery renin-angiotensin system
19. Definitive molecular evidence of RAS in human uterine decidual cells
20. Prostacyclin production during pregnancy: Comparison of production during normal pregnancy and pregnancy complicated by hypertension
21. 2 synthesis in pregnancy-induced hypertension
22. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies
23. Circulating endothelin-1 is not increased in severe preeclampsia
24. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia
25. Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women
26. The effect of S-nitrosoglutathione on platelet activation, hypertension and uterine and fetal Doppler in severe preeclampsia
27. Renin and reproduction
28. Eicosanoids in the pathogenesis of preeclampsia
29. The uteroplacental renin-angiotensin system in normal and hypertensive pregnancy
30. A study of angiotensin II pressor response throughout primigravid pregnancy
31. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene
32. The role of prostanoids in renin-dependent and renin-independent hypertension
33. Angiotensin induced hypertension in the rat: Sympathetic nerve activity and prostaglandins
34. Endothelial cell sodium-potassium-chloride cotransport: Evidence of regulation by Ca2+ and protein kinase C
35. Protein kinase C inhibitors potentiate angiotensin II-induced phosphoinositide hydrolysis and intracellular Ca2+ mobilization in renal mesangial cells
36. Na(+)-K+ pump and Na(+)-K cotransport in cultured vascular smooth muscle cells from spontaneously hypertensive and normotensive rats: Baseline activity and regulation
37. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells
38. Preeclampsia - A state of sympathetic overactivity
39. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen
40. Prorenin secretion from human placenta perfused in vitro
41. Reproductive tissue renin gene expression in preeclampsia
42. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnancy women: Deviations related to the development of superimposed preeclampsia
43. Role of renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure
44. A molecular variant of angiotensinogen associated with preeclampsia
45. Some observations on the incidence of pre-eclampsia
46. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort
47. Clinical and biochemical evidence of endothelial cell dysfunction in pregnancy syndrome preeclampsia
48. Increased frequency of genetic thrombophilia in women with complications of pregnancy
49. Relationship of maternal placental blood flow to the placental clearance of maternal plasma dehydro-isoandrosterone sulfate through placental estradiol formation
50. Early platelet consumption in preeclampsia
51. Coagulation changes in eclampsia: Their frequency and pathogenesis
52. Hypertension in pregnancy: Clinical-pathological correlations and remote prognosis
53. Hyperuricemia in preeclampsia
54. Effect of angiotensin and norepinephrine upon urate clearance in man
55. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy
56. Pregnancy induced hypertension complicated by acute liver disease and disseminated intravascular coagulation: Five case reports
57. Antepartum fetal assessment in hypertensive pregnancies
58. Syndrome of haemolysis, elevated liver enzymes, and low platelet count: A severe consequence of hypertension in pregnancy
59. Acute fatty liver of pregnancy
60. Acute fatty liver of pregnancy: Etiology of fetal distress and fetal wastage
61. Preeclampsia may cause both over-perfusion and underperfusion of the brain: A cerebral perfusion based on model
62. Standardized treatment of 154 consecutive cases of eclampsia
63. The treatment of hypertension in pregnancy
64. Causes of perinatal death associated with gestational hypertension and proteinuria
65. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy
66. Neonatal outcome of premature infants of mothers with preeclampsia
67. Parameters associated with adverse perinatal outcome in hypertensive pregnancies
68. Pregnancy outcome as related to hypertension, edema and proteinuria
69. Neonatal outcome after preterm delivery for preeclampsia
70. Maternal hypertension and neurodevelopmental outcome in very preterm infants
71. Growth and development at the age of 1.5 years in children with maternal hypertension
72. Infant neurodevelopmental outcome in pregnancies complicate gestational hypertension and intra-uterine growth retardation
73. Fetal cerebral maturation in hypertensive disorders of pregnancy
74. Umbilical artery Doppler ultrasound predicts low birth weight fetal death in hypertensive pregnancies
75. Fetal cerebral and renal Doppler in small for gestational age fetus in hypertensive pregnancies
76. Obstetric and neonatal outcome in fetuses with absent end-dias velocities of the umbilical artery: A case-controlled study
77. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
78. Conservative therapy of toxemia of pregnancy: Standard, innovative and experimental approaches
79. Hypertension in pregnancy
80. Management of pregnancy-induced hypertension in the nulliparous patient remote from term
81. Management of pregnancy-induced hypertension in the nullipara